VivoSim Labs (VIVS) Change in Inventory (2011 - 2024)

VivoSim Labs (VIVS) posted quarterly Change in Inventory of -$2000.0 for Q4 2024, down 100.51% quarter-over-quarter from $392000.0 in Q3 2024.

VivoSim Labs (VIVS) Change in Inventory (2011 - 2024) Analysis & Trends

VivoSim Labs' Change in Inventory history runs 10 years deep, the most recent figure standing at -$2000.0 for Q4 2024.

In Q4 2024, Change in Inventory changed N/A year-over-year to -$2000.0; the TTM figure through Sep 2025 stood at -$2000.0 (down 100.25% YoY), while the FY2025 annual figure was $501000.0, up 68.69% from the prior year.
Change in Inventory for Q4 2024 stood at -$2000.0, down from $392000.0 in the prior quarter.
The five-year high for Change in Inventory was $392000.0 in Q3 2024, with the low at -$2000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	132.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	47.15 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-280,000.00
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	135.26 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	12.97 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	VivoSim Labs	1.49 Mn	1.49 Mn	-	-

Download Data